Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 3, 2007

Sartorius Acquires Toha Plast

  • Sartorius acquired all shares in Toha Plast, which develops and manufactures plastic components for the medical and biotechnology industries. By acquiring Toha Plast, the Sartorius biotechnology division is continuing to expand its technological expertise in the field of plastics, according to the company.

    “Plastics technology has a high strategic significance,” points out Joachim Kreuzburg, CEO of Sartorius. “For this reason, we intend to have this technology available and further develop it within our own group.”

    Toha Plast has been a long-term supplier and development partner to Sartorius in plastics technology, including processing of thermoplastics and injection molding. Last July, Sartorius had already purchased a  small Toha Plast production facility in Puerto Rico.

    The company has about 75 employees at its location in Goettingen and possesses cleanroom production technology.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »